Beta Glucan Synbiotic: Stregnthening Heart - Gut Axis

The Beta Glucan Synbiotic Formula qualifies for the American Heart Association and Food and Drug Administration “Healthy Heart” seal of approval (FDA, 2002).

The suggested daily guideline of two tablespoons contains high concentration of oat beta glucan (10%) for cardiovascular support. Oat beta glucan is also shown in research to reduce serum LDL cholesterol and improve liver function (see research tab).

The Beta Glucan strengthens heart - gut axis with beta gluons and fiber for heart, red beet root for healthy vascular system, and a powerful mix of probiotics and fiber for the gut, effectively building a robust, healthy ecosystem (microbiome) in the gastrointestinal tract

The whole organic red beetroot (15%) and inulin from organic chicory fiber (10%) are also found to confer many exciting health benefits: energy production, antioxidants, bowel regularity, liver support, a gentle detox, and more. The beta glucan from oats are 99.98% gluten free. US Patent # 6,060,519.

Beta Glucan Synbiotic: Heart - Gut Axis

Yours as always,

Dohrea 

References

• Chen, W., Zhang, S., Wu, J., Ye, T., Wang, S., Wang, P., & Xing, D. (2020). Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clinica chimica acta, 507, 236-241.
• Desai, D., Desai, A., Jamil, A., Csendes, D., Gutlapalli, S. D., Prakash, K., ... & Khan, S. (2023). Re-defining the Gut Heart Axis: A Systematic Review of the Literature on the Role of Gut Microbial Dysbiosis in Patients With Heart Failure. Cureus, 15(2). Article
• Forkosh, E., & Ilan, Y. (2019). The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy. Open heart, 6(1), e000993.
• Hayashi, T., Yamashita, T., Takahashi, T., Tabata, T., Watanabe, H., Gotoh, Y., ... & Hirata, K. I. (2021). Uncovering the role of gut microbiota in amino acid metabolic disturbances in heart failure through metagenomic analysis. Frontiers in Cardiovascular Medicine, 8, 789325.
• Kamo, T., Akazawa, H., Suzuki, J. I., & Komuro, I. (2017). Novel concept of a heart-gut axis in the pathophysiology of heart failure. Korean circulation journal, 47(5), 663-669.
• Matsiras, D., Bezati, S., Ventoulis, I., Verras, C., Parissis, J., & Polyzogopoulou, E. (2023). Gut Failure: A Review of the Pathophysiology and Therapeutic Potentials in the Gut–Heart Axis. Journal of Clinical Medicine, 12(7), 2567.
• Sumida, K., & Kovesdy, C. P. (2019). The gut–kidney–heart axis in chronic kidney disease. Physiology International, 106(3), 195-206.
• Wang, Z., Cai, Z., Ferrari, M. W., Liu, Y., Li, C., Zhang, T., & Lyu, G. (2021). The correlation between gut microbiota and serum metabolomic in elderly patients with chronic heart failure. Mediators of Inflammation, 2021(1), 5587428.

We have developed our products based on scientific research and/or the practical experience of many healthcare practitioners. There is a growing body of literature on food based nutrition and supplements and their application in support of our health. Please use our products under the advisement of your doctor.  

My Research: International Day of Peace. 9.20.24